Logistics Leaders - How to successfully ship cell and gene therapies
How is cell and gene therapy evolving? Sam Herbert, President, discusses.
The evolution of the supply chain in traditional small and large molecules is a hand-off from clinical partners into commercial partners. The clinical supply chain has very little bearing on what the commercial supply chain ends up being, but this is totally different in cell and gene therapy. In cell and gene therapy, the clinical supply chain evolves and grows into what will be the commercial supply chain, incorporating more and more partners, more and more complexity, and so with selecting a partner for the clinical supply chain, a manufacturer really needs to think about whether this partner can grow into that full commercialization partner.